title: The evolution of temporary percutaneous mechanical circulatory support devices: a review of the options and evidence in cardiogenic shock.
abstract: Temporary percutaneous mechanical circulatory support (MCS) devices were introduced in the 1960s and have developed into a diverse portfolio of options currently available for left, right, and biventricular support. Patients undergoing high-risk percutaneous coronary interventions (PCI), patients with acute myocardial infarction (AMI), and patients with cardiogenic shock in particular may benefit from these options. In this review, we will discuss the currently available devices and the evidence supporting their use in cardiogenic shock.
authors.affiliation: Stanford University Medical Center, 300 Pasteur Drive, Stanford, CA, 94305, USA, abnousi@stanford.edu.
authors.forename: Freddy
authors.initials: F
authors.lastname: Abnousi
authors.forename: Celina Mei
authors.initials: CM
authors.lastname: Yong
authors.forename: William
authors.initials: W
authors.lastname: Fearon
authors.forename: Dipanjan
authors.initials: D
authors.lastname: Banerjee
mesh_terms: D000208:Acute Disease; D006353:Heart-Assist Devices / Q000145:classification*; D006801:Humans; D007423:Intra-Aortic Balloon Pumping / Q000295:instrumentation; D009203:Myocardial Infarction / Q000628:therapy*; D062645:Percutaneous Coronary Intervention; D012770:Shock, Cardiogenic / Q000628:therapy*